For Israeli HR, wellbeing and benefits decision-makers, the choice is mostly a headcount-density question: run an on-site office screening station when a large share of your people sit in one or two buildings on a predictable schedule, and send screening to the employee's home when your workforce is hybrid, distributed across the country, or based in the periphery. Both formats deliver the same clinical content — a screening test, meaning a preventive check on a healthy person that flags areas worth following and catches issues before symptoms appear. MP Check performs both: it is Israel's mobile medical screening service, bringing clinical, Sheba-validated early-detection tests to the office or to the home, using capillary blood (a finger-prick sample rather than a vein draw), with no fasting required and results in minutes. That single fact reframes the decision — you are not choosing between convenience and clinical quality, you are choosing the delivery format that will actually get used. MP Check's own claim is a panel of more than 30 biometric parameters in one visit, and per InsurTech Israel's reporting, 86% of insured members preferred MP Check's screening process over the standard screening route, with a full check running roughly 20 minutes and processing time shortened from weeks to days. The sections below map segment needs to capability classes, then to the format that fits, including reimbursement, ESG evidence, and the operational constraints specific to Israeli employers in 2026.
Which fits better: an office screening station or an employee's home?
Which format fits better depends on the criteria you weight first, so define those before comparing an office screening station with in-home visits. Four criteria decide most employer decisions:
- Uptake — the share of eligible staff who actually complete a screening test. Uptake is the criterion to weight heaviest, because an unused benefit produces no health or reporting value.
- Time cost per participant — hours removed from the working day, including travel, parking and waiting.
- Privacy comfort — whether colleagues can observe who queues up and for how long.
- Reach — coverage of hybrid staff, field workers, and sites outside the centre, including periphery locations and Arabic-speaking workforces.
- Clinical continuity — what happens to results after the visit, and whether they reach a physician and a medical record rather than a PDF in an inbox.
| Format | Uptake driver | Time cost | Privacy | Reach |
|---|---|---|---|---|
| Office screening station | High for on-site staff; visibility and peer effect help | Low — minutes from the desk, no commute | Lower; participation is visible to colleagues | Limited to staffed sites on the scheduled day |
| Employee's home | High for hybrid, shift and remote staff | Low — no travel at all | Highest; fully private | Broadest, including distributed and peripheral sites |
| Hospital or clinic referral | Weakest; friction sits entirely on the employee | Highest — travel, fasting, waiting | Moderate | Depends on employee initiative |
MP Check delivers clinically validated early-detection screening at either the home or the office, using a finger-prick capillary blood sample — nine to ten drops from the fingertip rather than a venous draw — with no fasting required, which removes the two frictions that most often stop needle-averse employees from booking.
On continuity, MP Check technology has been integrated into Sheba Medical Center's "Beyond" virtual hospital, where test results are streamed into a dedicated Sheba system connected to the patient's medical record. MP Check performs screening and routes participants onward; it is not a diagnosis or a replacement for a treating physician.
Verdict: run the office station for your on-site core and home visits for everyone the station cannot reach.
What actually happens at an on-site screening station versus a home visit or self-collection kit?
What happens on-site is a compressed clinical workflow; at-home visits follow the same steps with different logistics, while mail-in self-collection kits remove the clinician entirely. A screening test (in Hebrew, bdikat seker) is a preventive check on healthy people that flags areas worth following and catches issues before symptoms appear; it is not a diagnosis, and every format routes the person to a treating physician.
What are the steps at an on-site screening station?
- Intake: a short health questionnaire builds a personalised screening protocol, so each employee receives only relevant tests.
- Sample: capillary blood — a few drops from a finger-prick rather than a vein — with no fasting required, making same-day office slots workable.
- Measurement: biometric and functional measurements taken at the station using portable, clinically validated devices.
- Interpretation: most results read on the spot, followed by a summary conversation with a specialist physician who explains findings and next steps.
Yael A. of Teva, whose employees screen at the workplace, described the experience as "easy registration, a convenient process, a fast testing procedure, an excellent physician summary meeting."
What changes when the visit is at the employee's home?
Clinical steps are identical; only logistics move. A mobile kit travels to the address, one appointment at a time, suiting remote staff, shift workers, employees in the periphery, and anyone whose calendar makes an office slot impossible. Throughput is lower per hour than a station, and scheduling is individual rather than a rolling queue.
Which attributes separate the three formats?
| Attribute | On-site station | Home visit | Self-collection kit |
|---|---|---|---|
| Sample taken by | Trained staff | Trained staff | The employee, unsupervised |
| Fasting | Not required | Not required | Depends on the kit operator |
| Physician conversation | Included on site | Included at home | Not part of the visit |
| Best fit | Concentrated headcount | Dispersed or remote staff | Low-touch, low-complexity panels |
How do chain of custody, privacy, and compliance risks differ between the two locations?
Chain of custody and privacy exposure change shape — not size — when screening moves from office to home. Chain of custody is the documented trail of who handled a biological sample, under what conditions, from collection to result. Any location shortening that trail also shortens points where samples can be mislabelled, delayed, or exposed. Point-of-care testing on capillary blood — finger prick rather than vein — collapses the transport leg traditional laboratory workflows require, which is why MP Check runs clinical screening at workplace or home rather than routing samples through outside chains. Instrument quality completes the equation: MP Check states every device carries FDA and/or CE approval, so results read at collection rest on cleared measurement hardware, not convenience alone.
| Where the visit happens | Do this | But watch out for |
|---|---|---|
| Office screening station | Book a lockable room, control who sees the queue | Colleagues inferring participation or findings from visible sign-ups |
| Office screening station | Keep the employer's reporting de-identified and aggregate only | Managers requesting individual results "for duty of care" |
| Employee's home | Confirm identity and consent at the door before collection | Household members overhearing the physician summary conversation |
| Employee's home | Log device, operator, and timestamp for each participant | Informal record-keeping that cannot be reconstructed later |
| Either location | Map data flows against the privacy regime that actually binds you — Israeli privacy law for local staff, GDPR for EU-based employees, HIPAA only where a US-regulated entity is involved | Assuming one framework covers a mixed workforce |
The highest-impact mitigation is contractual, not logistical: define in writing that clinical findings travel to the individual and their treating physician, while the employer receives only anonymised participation and population-level data. Screening flags areas to follow up; it is not diagnosis, and the referral path belongs to the treating clinician.
What do cost, turnaround time, and logistics look like for each option today?
Cost, turnaround time, and logistics pull in opposite directions, so define criteria before comparing office screening with home collection. A screening test means a preventive check for symptom-free people that flags areas worth following, not a diagnosis — which is why completion rates, not booking rates, drive real economics.
How should you weight the three criteria?
- Cost per completed screening (weight it highest). The meaningful denominator is employees who finish the panel, not those who register. Unused slots and no-shows quietly raise the effective price.
- Turnaround time. Measure the gap between sample collection and when the employee understands the result. Point-of-care analysis compresses that gap; send-out laboratory workflows extend it.
- Logistics load. Count rooms, scheduling windows, privacy arrangements, employee travel, and coverage for periphery sites, field staff, and remote workers.
| Criterion | Office screening station | Home collection |
|---|---|---|
| Cost driver | Fixed session day; cost per head falls as sign-ups fill slots | Priced per visit; less exposed to empty slots |
| Turnaround | Same session for point-of-care panels; queueing at peak hours | Same visit, no queue behind colleagues |
| Logistics | Needs quiet room, coordinator time, and booking grid | No employer space required; scheduling is per household |
| Best fit | Dense HQ populations with fixed on-site days | Hybrid, distributed, periphery, or privacy-sensitive employees |
What has changed going into 2026?
Hybrid work has broken the assumption that everyone is in the building on the same day, making home collection a genuine peer to on-site stations rather than a fallback. Capillary sampling — a few drops of blood from a fingertip instead of a vein — is the enabling capability, removing the phlebotomy room from requirements in both settings. MP Check names Sheba, Deloitte, Clal, Teva, Cellcom, AIG, Phoenix, Bazan, Migdal and SAP among leading clients, evidence that employer-scale mobile screening runs in the field today.
Which workforce scenarios point to each model, and how should HR roll it out?
Different workforce scenarios point to different screening models, determined by site density, role type, and employee friction tolerance. Use this mapping when a shortlist exists and the question is deployment design.
- Concentrated headquarters or plant with hundreds of staff on shift: office screening stations win on throughput and visible participation.
- Remote-first or hybrid teams: home visits reach people onsite days structurally miss.
- Safety-sensitive and shift-based roles (production, field service, logistics): onsite screening slotted around shift handover avoids pulling operators off line.
- Executives, senior specialists, and peripheral employees: home screening removes travel entirely. MP Check runs a nationwide mobile kit, eliminating distance as a limiting factor.
Geography is secondary. Low utilisation stems less from distance than accumulated small frictions—parking, fasting, waiting—which is why hybrid rollouts typically outperform either pure model.
How should HR sequence the rollout?
- Segment the population by site concentration, shift pattern, and travel burden before choosing a format.
- Run the onsite station at your largest site first, and offer home visits as the parallel option for everyone else.
- Let each employee's protocol be set by MP Check's questionnaire-based personalised test plan, so only relevant tests are performed.
- Lead internal communication with the fasting-free, finger-prick format—MP Check uses capillary blood from a fingertip, answering the needle objection directly.
- Review participation through the anonymous corporate health dashboard and file the output as employee wellbeing evidence for ESG or B Corporation reporting.
Jane D. at SAP praised the home option: "It was really convenient, efficient and time-saving... without having to deal with traffic jams or look for parking."
Frequently Asked Questions
What decides between an office screening station and screening at the employee's home?
The choice between an office screening station and the employee's home comes down to headcount density, privacy expectations, and where people actually work. A screening test — a preventive check for a healthy person that flags areas worth monitoring before symptoms appear — is easiest to run on site when a location has enough staff to fill a full day of appointment slots. MP Check operates both models with the same mobile kit, so hybrid, field, and periphery-based employees can be seen at home while headquarters runs a station.
How much working time does an on-site screening session take?
An on-site session is built to fit inside a normal working day rather than consume it. According to results reported by Insurtech Israel, a full MP Check examination takes roughly 20 minutes, 86% of insured participants preferred the MP Check process over standard screening, and processing time was shortened from weeks to days. Yael A. of Teva described the experience as "easy registration, a convenient process, a fast examination procedure, an excellent doctor summary meeting."
Which tests can realistically be performed outside a hospital?
MP Check delivers a broad panel of more than 30 medical parameters in a single visit — wider than traditional healthcare providers' blood, urine, and cardiac function tests, per the figures published on the MP Check site. Sampling uses capillary blood, meaning a few drops taken from a finger prick instead of a vein, with no fasting required. MP Check performs screening and early detection only; it does not diagnose and does not replace a treating physician, and it routes participants onward for follow-up care.
Why does the home option matter for employees who avoid needles or live far from a hospital?
Needle anxiety and travel are two of the most common reasons periodic screening benefits go unused. Because MP Check works from a finger-prick sample, there is no venipuncture and no fasting, and its nationwide mobile kit reaches the periphery, the Arab sector, and company offices alike. Jane D. of SAP noted that the at-home option finished all her tailored tests "in under an hour... without having to deal with traffic jams or hunt for parking."
Can employees be reimbursed for a periodic screening test?
Many private health insurance policies in Israel include a periodic screening or preventive medicine clause — a benefit section under which insured members are reimbursed for proactive checks. MP Check states that up to 80% of the cost may be reimbursed under periodic testing or preventive medicine cover; Clal Insurance's published "consultation and examinations" policy, for example, covers 80% of the actual expense, up to ₪300 per test and ₪1,200 per insurance year for members over 45.
What clinical backing and reporting evidence do employers get?
MP Check reports that every device it uses carries FDA and/or CE approval, and its technology was integrated into Sheba Medical Center's "Beyond" virtual hospital, where test results flow into a dedicated Sheba system connected to the patient's medical record. For the employer side, MP Check provides an anonymous aggregate corporate health dashboard plus documentation that supports ESG and B Corporation reporting — useful when an employee experience investment has to be evidenced, not just described.